Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$64.4M |
| 2 |
DuPont de Nemours
DD
|
+$35.6M |
| 3 |
Alibaba
BABA
|
+$35.4M |
| 4 |
Apple
AAPL
|
+$34.3M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$28.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.3M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$46.6M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$40.7M |
| 4 |
Comcast
CMCSA
|
+$38.1M |
| 5 |
PG&E
PCG
|
+$31.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.94% |
| 2 | Financials | 10.6% |
| 3 | Healthcare | 8.31% |
| 4 | Industrials | 7.75% |
| 5 | Consumer Discretionary | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPUS
1576
Hyperscale Data Inc
GPUS
| – | – |
0
| – | – |
|
|
VAPO
1577
PUT
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $115K | ﹤0.01% |
+500
| New | +$144K |
|
|
EXAS
1578
DELISTED
Exact Sciences
EXAS
| $111K | ﹤0.01% |
1,085
-27,143
| -96% | -$2.34M |
|
|
HTT
1579
High Templar Tech Ltd
HTT
$393M
| $111K | ﹤0.01% |
+89,864
| New | +$152K |
|
|
CAMP
1580
DELISTED
CalAmp Corp.
CAMP
| $110K | ﹤0.01% |
662
-741
| -53% | -$139K |
|
|
DESP
1581
DELISTED
Despegar.com
DESP
| $108K | ﹤0.01% |
16,961
-24,239
| -59% | -$193K |
|
1582
Patterson-UTI
PTEN
$4.52B
| $108K | ﹤0.01% |
+37,823
| New | +$139K |
|
|
SBBP
1583
DELISTED
Strongbridge Biopharma plc.
SBBP
| $107K | ﹤0.01% |
+50,782
| New | +$171K |
|
1584
Cyclerion Therapeutics
CYCN
$18.4M
| $105K | ﹤0.01% |
+867
| New | +$99.1K |
|
|
CIO
1585
DELISTED
City Office REIT
CIO
| $103K | ﹤0.01% |
+13,707
| New | +$119K |
|
|
MRC
1586
DELISTED
MRC Global
MRC
| $103K | ﹤0.01% |
24,150
+14,094
| +140% | +$81K |
|
1587
Prospect Capital
PSEC
$1.16B
| $103K | ﹤0.01% |
+20,530
| New | +$103K |
|
1588
Cameco
CCJ
$44.5B
| $102K | ﹤0.01% |
+10,090
| New | +$109K |
|
1589
Xeris Biopharma Holdings
XERS
$1.59B
| $100K | ﹤0.01% |
16,867
-15,715
| -48% | -$62.8K |
|
1590
Caleres
CAL
$459M
| $99K | ﹤0.01% |
10,315
-17,199
| -63% | -$138K |
|
1591
McEwen Inc
MUX
$1.29B
| $99K | ﹤0.01% |
9,302
+7,211
| +345% | +$87.4K |
|
|
WSR
1592
DELISTED
Whitestone REIT
WSR
| $99K | ﹤0.01% |
+16,425
| New | +$107K |
|
|
NGD
1593
DELISTED
New Gold Inc
NGD
| $98K | ﹤0.01% |
+57,363
| New | +$92.2K |
|
|
DHC
1594
Diversified Healthcare Trust
DHC
$1.94B
| $97K | ﹤0.01% |
27,445
-15,963
| -37% | -$62.3K |
|
1595
Rigel Pharmaceuticals
RIGL
$843M
| $96K | ﹤0.01% |
3,991
+1,681
| +73% | +$41.3K |
|
1596
LG Display
LPL
$3.29B
| $95K | ﹤0.01% |
+14,499
| New | +$85.4K |
|
|
CSPR
1597
DELISTED
Casper Sleep Inc.
CSPR
| $95K | ﹤0.01% |
+13,202
| New | +$110K |
|
|
LADR
1598
Ladder Capital
LADR
$1.27B
| $94K | ﹤0.01% |
+13,194
| New | +$99.2K |
|
1599
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $93K | ﹤0.01% |
+2,100
| New | +$92.1K |
|
1600
KALA BIO
KALA
$15.4M
| $93K | ﹤0.01% |
5
-3
| -38% | -$69K |
|
Similar funds
Michael Gelband's Q3 2020 Portfolio in Review
As of Q3 2020, Michael Gelband held 2,471 positions worth $5.02B, up 30% from $3.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Michael Gelband deployed $816M of net new capital in Q3 2020, opening 743 new positions and adding to 409 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $46.6M trimmed.
- Michael Gelband's largest Q3 2020 buy was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
- Michael Gelband added most to Charles Schwab in Q3 2020, an estimated $64.4M increase.
- Michael Gelband's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $46.6M.
- Michael Gelband fully exited State Street SPDR S&P 500 ETF Trust in Q3 2020, selling an estimated $88.3M.
- Michael Gelband's ten largest holdings make up 32% of its $5.02B portfolio in Q3 2020.
- Michael Gelband opened 743 new positions and closed 789 in Q3 2020.
- Michael Gelband's portfolio value rose 30% quarter-over-quarter to $5.02B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.